Barry Shulkin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Barry shulkin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Barry Shulkin Today - Breaking & Trending Today

Society of Nuclear Medicine and Molecular Imaging Names Helen Nadel, MD, FRCPC, of Stanford, as President, Announces New Officers at SNMMI 2023 Annual Meeting

During its 2023 Annual Meeting, held June 24-27 in Chicago, the Society of Nuclear Medicine and Molecular Imaging (SNMMI). SNMMI named Helen Nadel, MD, FRCPC, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford (CA), and clinical professor of radiology at the Stanford School of Medicine, as its President, introduced its new slate of officers and recognized 10 new fellows. ....

Salt Lake City , United States , New York , University Of California Davis , United Kingdom , Stanford University , University Of Utah , Johns Hopkins University , British Columbia , Stanford School , Helen Nadel , John Hoffman , Jean Lucc Urbain , Martin Pomper , Munir Ghesani , Gary Ulaner , Ramsey Badawi , Barry Shulkin , Arman Rahmim , Andrei Iagaru , Erin Grady , University Of Utah School Medicine , Pediatric Imaging Council , Brookhaven National Laboratory In Upton , Children Oncology Group , Jude Children Research Hospital ,

Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma


Date Time
Excellent outcomes reported for first targeted frontline therapy for high-risk pediatric Hodgkin lymphoma
(From left) First and corresponding author Monika Metzger, M.D., Departments of Oncology and Global Pediatric Medicine; co- senior author Matthew Krasin, M.D., Department of Radiation Oncology; and co-senior author Melissa Hudson, M.D., Cancer Survivorship Division director.
Scientists are reporting results of the first frontline clinical trial to use targeted therapy to treat high-risk pediatric Hodgkin lymphoma. The study showed that the addition of brentuximab vedotin achieved excellent outcomes, reduced side effects, and allowed for reduced radiation exposures.
The study was the result of work by a multi-site consortium dedicated to pediatric Hodgkin-lymphoma. Collaborating institutions include St. Jude Children’s Research Hospital, Stanford University School of Medicine, Dana-Farber Cancer Institute, Massachusetts General Hospital, Maine Childr ....

United States , Dana Farber Cancer Institute , Belinda Mandrell , Susan Hiniker , Alison Friedmann , John Lucas Jr , Sandra Luna Fineman , Chen Li , Matthew Ehrhardt , Matthew Krasin , Monika Metzger , Nickhill Bhakta , Amy Billett , Melissa Hudson , Hodgkin Reed Sternberg , Zhaohua Lu , Barry Shulkin , Jamie Flerlage , Eric Larson , Nemours Alfredi Dupont , Torunn Yock , Sarah Donaldson , National Cancer Institute , Jude Children Research Hospital , Judecancer Survivorship Division , Stanford University School Of Medicine ,